BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

564 related articles for article (PubMed ID: 29192312)

  • 1. Association of Lymph Node Density With Survival of Patients With Papillary Thyroid Cancer.
    Amit M; Tam S; Boonsripitayanon M; Cabanillas ME; Busaidy NL; Grubbs EG; Lai SY; Gross ND; Sturgis EM; Zafereo ME
    JAMA Otolaryngol Head Neck Surg; 2018 Feb; 144(2):108-114. PubMed ID: 29192312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer.
    Wu MH; Shen WT; Gosnell J; Duh QY
    Head Neck; 2015 Sep; 37(9):1336-43. PubMed ID: 24821456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymph node density is a significant predictor of outcome in patients with oral cancer.
    Gil Z; Carlson DL; Boyle JO; Kraus DH; Shah JP; Shaha AR; Singh B; Wong RJ; Patel SG
    Cancer; 2009 Dec; 115(24):5700-10. PubMed ID: 19691095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for skip metastasis and lateral lymph node metastasis of papillary thyroid cancer.
    Zhao H; Huang T; Li H
    Surgery; 2019 Jul; 166(1):55-60. PubMed ID: 30876667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of lymph node density in node-positive patients with oral squamous cell carcinoma.
    Kim SY; Nam SY; Choi SH; Cho KJ; Roh JL
    Ann Surg Oncol; 2011 Aug; 18(8):2310-7. PubMed ID: 21336511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modification of the eight-edition tumor-node-metastasis staging system with N1b for papillary thyroid carcinoma: A multi-institutional cohort study.
    Kim M; Kim HK; Kim HI; Kim EH; Jeon MJ; Yi HS; Kim ES; Kim H; Kim TH; Kim BH; Kim TY; Kang HC; Kim WB; Chung JH; Shong YK; Kim SW; Kim WG
    Oral Oncol; 2018 Nov; 86():48-52. PubMed ID: 30409319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymph node density in oral cavity cancer: results of the International Consortium for Outcomes Research.
    Patel SG; Amit M; Yen TC; Liao CT; Chaturvedi P; Agarwal JP; Kowalski LP; Ebrahimi A; Clark JR; Cernea CR; Brandao SJ; Kreppel M; Zöller J; Fliss D; Fridman E; Bachar G; Shpitzer T; Bolzoni VA; Patel PR; Jonnalagadda S; Robbins KT; Shah JP; Gil Z;
    Br J Cancer; 2013 Oct; 109(8):2087-95. PubMed ID: 24064974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease-specific survival after radical lymphadenectomy for penile cancer: prediction by lymph node count and density.
    Li ZS; Yao K; Chen P; Zou ZJ; Qin ZK; Liu ZW; Li YH; Zhou FJ; Han H
    Urol Oncol; 2014 Aug; 32(6):893-900. PubMed ID: 24994488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Implications of Lymph Node Yield in Central and Lateral Neck Dissections for Well-Differentiated Papillary Thyroid Carcinoma.
    Heaton CM; Chang JL; Orloff LA
    Thyroid; 2016 Mar; 26(3):434-40. PubMed ID: 26825749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does the T1 subdivision correlate with the risk of recurrence of papillary thyroid cancer?
    Chereau N; Trésallet C; Noullet S; Godiris-Petit G; Tissier F; Leenhardt L; Menegaux F
    Langenbecks Arch Surg; 2016 Mar; 401(2):223-30. PubMed ID: 26957089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Head-to-head comparison of lymph node density and number of positive lymph nodes in stratifying the outcome of patients with lymph node-positive prostate cancer submitted to radical prostatectomy and extended lymph node dissection.
    Passoni NM; Abdollah F; Suardi N; Gallina A; Bianchi M; Tutolo M; Fossati N; Gandaglia G; Salonia A; Freschi M; Rigatti P; Montorsi F; Briganti A
    Urol Oncol; 2014 Jan; 32(1):29.e21-8. PubMed ID: 23490908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic impact of incomplete surgical clearance of radioiodine sensitive local lymph node metastases diagnosed by post-operative (124)I-NaI-PET/CT in patients with papillary thyroid cancer.
    Sabet A; Binse I; Grafe H; Ezziddin S; Görges R; Poeppel TD; Bockisch A; Rosenbaum-Krumme SJ
    Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):1988-94. PubMed ID: 27118127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adequate lymph node dissection is essential for accurate nodal staging in intrahepatic cholangiocarcinoma: A population-based study.
    Zhu J; Liu C; Li H; Ren H; Cai Y; Lan T; Wu H
    Cancer Med; 2023 Apr; 12(7):8184-8198. PubMed ID: 36645113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymph node density for patient counselling about prognosis and for designing clinical trials of adjuvant therapies after radical cystectomy.
    Lee EK; Herr HW; Dickstein RJ; Kassouf W; Munsell MF; Grossman HB; Dinney CP; Kamat AM
    BJU Int; 2012 Dec; 110(11 Pt B):E590-5. PubMed ID: 22758775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. More lymph node dissection improves survival in patients with newly diagnosed lymph node-positive penile cancer.
    Mao W; Huang X; Kong M; Fan J; Geng J
    Int Urol Nephrol; 2019 Apr; 51(4):641-654. PubMed ID: 30758771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Lobectomy vs Total Thyroidectomy for Intermediate-Risk Papillary Thyroid Carcinoma With Lymph Node Metastasis.
    Xu S; Huang H; Huang Y; Qian J; Wang X; Xu Z; Liu S; Liu J
    JAMA Surg; 2023 Jan; 158(1):73-79. PubMed ID: 36449303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for local recurrence following lateral neck dissection for papillary thyroid carcinoma.
    Raffaelli M; De Crea C; Sessa L; Tempera SE; Belluzzi A; Lombardi CP; Bellantone R
    Endocrine; 2019 Feb; 63(2):310-315. PubMed ID: 30341706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying risk factors of recurrence for clinically node negative papillary thyroid carcinoma with pathologic N1a.
    Ryu YJ; Cho JS; Park MH; Yoon JH
    BMC Surg; 2019 Jul; 19(1):78. PubMed ID: 31277631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of Hashimoto Thyroiditis in Adults With Papillary Thyroid Cancer and Its Association With Cancer Recurrence and Outcomes.
    Xu S; Huang H; Qian J; Liu Y; Huang Y; Wang X; Liu S; Xu Z; Liu J
    JAMA Netw Open; 2021 Jul; 4(7):e2118526. PubMed ID: 34313737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presence and Number of Lymph Node Metastases Are Associated With Compromised Survival for Patients Younger Than Age 45 Years With Papillary Thyroid Cancer.
    Adam MA; Pura J; Goffredo P; Dinan MA; Reed SD; Scheri RP; Hyslop T; Roman SA; Sosa JA
    J Clin Oncol; 2015 Jul; 33(21):2370-5. PubMed ID: 26077238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.